We discovered the emergence of a novel microglia subtype, Early-stage AD-Associated Microglia (EADAM), that is selectively induced by both Aβ and tau pathologies but not either Aβ or tau pathologies alone, during early-stage disease before AD-like pathologies are observed. The gene discussed is MAPT; the disease is Alzheimer disease.